Alberta Minister of Health Tyler Shandro announces the province is working with Novartis Pharmaceuticals Canada Inc. to provide children suffering from spinal muscular atrophy access to the drug Zolgensma.
Canada
Alberta announces interim access to Zolgensma for children suffering from spinal muscular atrophy
More Videos
-
Alberta Municipalities ‘caught off guard’ by details of Bill 20
-
Heavy snow causes tree damage, power outages in Calgary
-
Denver looks to Calgary for solutions to downtown vacancy woes
-
Calgary U18 AAA Buffaloes return home with bronze medal from Telus Cup
-
Alberta announces plans for future passenger rail service
-
Calgary school principal charged with possessing, accessing child pornography
You are viewing an Accelerated Mobile Webpage.
View Original Article